Residual Scope: A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients

Badgett, James (PI)
Bayliff, Sherry (Former CoI)
D'Orazio, John (Former CoI)
Geil, John (Former CoI)
Radulescu, Vlad (Former CoI)
Shaw, Angela (Former CoI)
Sorge, Caryn (Former CoI)

Pediatrics

1 resultados

Filtro

Terminado
A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphobl
Badgett, J. (PI), Bayliff, S. (Former CoI), D'Orazio, J. (Former CoI), Geil, J. (Former CoI), Radulescu, V. (Former CoI), Shaw, A. (Former CoI) & Sorge, C. (Former CoI)
Public Health Institute
6/28/19 → 2/28/26
Proyecto: Research project